These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 26819280)

  • 1. ATAD2 overexpression is associated with progression and prognosis in colorectal cancer.
    Hou M; Huang R; Song Y; Feng D; Jiang Y; Liu M
    Jpn J Clin Oncol; 2016 Mar; 46(3):222-7. PubMed ID: 26819280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATAD2 is overexpressed in gastric cancer and serves as an independent poor prognostic biomarker.
    Zhang M; Zhang C; Du W; Yang X; Chen Z
    Clin Transl Oncol; 2016 Aug; 18(8):776-81. PubMed ID: 26527032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of ATPase family AAA domain-containing protein 2 inhibits migration and invasion of colorectal cancer cells.
    Hong S; Bi M; Yan Z; Sun D; Ling L; Zhao C
    Neoplasma; 2016; 63(6):846-855. PubMed ID: 27565322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
    Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
    Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of ANCCA/ATAD2 in endometrial carcinoma and its correlation with tumor progression and poor prognosis.
    Shang P; Meng F; Liu Y; Chen X
    Tumour Biol; 2015 Jun; 36(6):4479-85. PubMed ID: 25934333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of ATPase family, AAA+ domain containing 2 expression in human cancers: A systematic review and meta-analysis.
    Han HJ; Huang QY; Huang LJ; Chang F; Diao QZ
    Medicine (Baltimore); 2019 Sep; 98(39):e17180. PubMed ID: 31574824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silence of ATAD2 inhibits proliferation of colorectal carcinoma via the Rb-E2F1 signaling.
    Wang JH; Yu TT; Li Y; Hao YP; Han L; Xu KY; Xu P
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6055-6063. PubMed ID: 32572920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of eukaryotic initiation factor 5A2 (EIF5A2) is associated with cancer progression and poor prognosis in patients with early-stage cervical cancer.
    Yang SS; Gao Y; Wang DY; Xia BR; Liu YD; Qin Y; Ning XM; Li GY; Hao LX; Xiao M; Zhang YY
    Histopathology; 2016 Aug; 69(2):276-87. PubMed ID: 26799253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DEK over expression as an independent biomarker for poor prognosis in colorectal cancer.
    Lin L; Piao J; Gao W; Piao Y; Jin G; Ma Y; Li J; Lin Z
    BMC Cancer; 2013 Jul; 13():366. PubMed ID: 23902796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATAD2 as a Poor Prognostic Marker for Hepatocellular Carcinoma after Curative Resection.
    Hwang HW; Ha SY; Bang H; Park CK
    Cancer Res Treat; 2015 Oct; 47(4):853-61. PubMed ID: 25687855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of NF-E1b in colorectal cancer tissues and its clinical significance].
    Xu K; Chen L; Di J; Wang Z; Wang A; Wu W; Wu F; Jiang B; Su X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jun; 19(6):685-9. PubMed ID: 27353105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a rationale to record lymphatic invasion in node-positive colorectal cancer?
    Betge J; Schneider NI; Pollheimer MJ; Lindtner RA; Kornprat P; Schlemmer A; Rehak P; Langner C
    J Clin Pathol; 2012 Sep; 65(9):847-50. PubMed ID: 22569541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGFBI protein high expression predicts poor prognosis in colorectal cancer patients.
    Zhu J; Chen X; Liao Z; He C; Hu X
    Int J Clin Exp Pathol; 2015; 8(1):702-10. PubMed ID: 25755764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer.
    Shen X; Bai Y; Luo B; Zhou X
    Biol Res; 2017 Oct; 50(1):32. PubMed ID: 28969673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic significance of TRAP1 expression in colorectal cancer: a large scale study of human colorectal adenocarcinoma tissues.
    Pak MG; Koh HJ; Roh MS
    Diagn Pathol; 2017 Jan; 12(1):6. PubMed ID: 28088229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gab2 is a novel prognostic factor for colorectal cancer patients.
    Ding C; Luo J; Yu W; Gao S; Yang L; Chen C; Feng J
    Int J Clin Exp Pathol; 2015; 8(3):2779-86. PubMed ID: 26045784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of NETO2 expression correlates with tumor progression and poor prognosis in colorectal carcinoma.
    Hu L; Chen HY; Cai J; Yang GZ; Feng D; Zhai YX; Gong H; Qi CY; Zhang Y; Fu H; Cai QP; Gao CF
    BMC Cancer; 2015 Dec; 15():1006. PubMed ID: 26699544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogene ATAD2 promotes cell proliferation, invasion and migration in cervical cancer.
    Zheng L; Li T; Zhang Y; Guo Y; Yao J; Dou L; Guo K
    Oncol Rep; 2015 May; 33(5):2337-44. PubMed ID: 25813398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.